Dexamethasone enhances the lung metastasis of breast cancer via a PI3K-SGK1-CTGF pathway

Dexamethasone (Dex), as a pretreatment agent, is widely used to attenuate the side effects of chemotherapy in breast cancer treatment. However, whether and how Dex affects breast cancer metastasis remain to be furtherly understood. In this study, we established several mouse breast cancer metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yujing, Shi, Gang, Zhang, Hantao, Xiong, Qi, Cheng, Fuyi, Wang, Huiling, Luo, Jieyan, Zhang, Yong, Shi, Pengyi, Xu, Jia, Fu, Jiamei, Chen, Na, Cheng, Lin, Li, Yiming, Dai, Lei, Yang, Yang, Yu, Dechao, Zhang, Shuang, Deng, Hongxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413128/
https://www.ncbi.nlm.nih.gov/pubmed/34272474
http://dx.doi.org/10.1038/s41388-021-01944-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413128/
https://www.ncbi.nlm.nih.gov/pubmed/34272474
http://dx.doi.org/10.1038/s41388-021-01944-w

Ejemplares similares